Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03043170 |
Other study ID # |
CardiffU |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
March 1, 2017 |
Est. completion date |
August 31, 2018 |
Study information
Verified date |
January 2021 |
Source |
Cardiff University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Background to the research Patients present to Emergency Departments (ED) with a spectrum of
illness, many of which are life- threatening. The body has the ability to compensate in the
early stages when things go wrong so that on the surface patients do not appear as sick as
they really are. Under-diagnosis of severity of illness leads to under-treatment, unnecessary
mortality, and unnecessary hospital costs. Earlier diagnosis and consequent treatment will
result in prudent healthcare, cost-benefit and better patient outcomes.
Evaluating the true underlying patient haemodynamics such as cardiac output, cardiac power
and peripheral pressures gives vital clues to the hidden seriousness of illness and is a
guide to better management. Few EDs in the world assess such haemodynamics. After evaluating
a haemodynamic protocol one centre in Australia was able to reduce its death rate for septic
shock at 30 days from 38% to 7%. We would like to evaluate whether the same would occur if
applied across EDs in Wales. However, before we can do that we need to strengthen our
understanding of haemodynamics, and of relevant protocols and non-invasive devices that help
us to acquire such information.
Study Design After ethics and institutional approval is obtained from we will conduct a
prospective, single-centre, cohort study on 354 adult patients with possible shock associated
with an acute illness or injury who present to the Emergency Department of the University
Hospital of Wales, and follow them up for 7 days. 354 is a credible number to confirm that
the strategy works.
Written consent will be obtained either from the patient or a relative wherever possible but
a waiver of consent apply to patients who, because of confusion, unconsciousness or severe
disability, may be unable to give consent. In these cases, consent will first be sought from
a second doctor and/or nurse. Thereafter, consent will be obtained from the patient or a
relative as soon as practically possible.
What you hope to discover
We expect to discover that:
- Uscom variables predict 7-day survival and ICU admission
- Uscom variables improve the detection and classification of shock
- The LiPS definition can be improved.
- The objective definition is better than doctors experience
- Patients have a good experience and are satisfied with care
Description:
Patients frequently present to emergency departments (EDs) with critical illness and injury.
Shock is a life-threatening emergency, which requires urgent and rapid assessment, diagnosis
and treatment, and can be classified into distributive-septic (62%), distributive-non-septic
(4%), hypovolaemic (16%), cardiogenic (16%) and obstructive (2%). Sepsis is the leading cause
of in-hospital death, and approximately 80% of these patients are admitted through the ED. In
Chinese patients presenting to an ED in Hong Kong we have previously derived and validated a
simple, a priori, pragmatic, quantitative method for recognising and classifying shock - Li's
Practical Shock (LiPS) tool. This method has been validated against ICU admission and early
mortality. However, it was derived in a single population in a single centre, and requires
further validation and refined in other settings. Further, it does not sub-classify patients
beyond 'normal, cold and warm shock', does not guide next steps in treatment, and the
assessment of the peripheries is very subjective.
Evaluating the true underlying patient haemodynamics such as cardiac output, cardiac power
and peripheral pressures gives vital clues to the hidden seriousness of illness and is a
guide to better management. Few EDs in the world assess such haemodynamics. After evaluating
a haemodynamic protocol one centre in Australia was able to reduce its death rate for septic
shock at 30 days from 38% to 7%. We would like to evaluate whether the same would occur if
applied across EDs in Wales. However, before we can do that we need to strengthen our
understanding of haemodynamics, and of relevant protocols and non-invasive devices that help
us to acquire such information.
There are many unanswered questions such as:
- Do Uscom-derived haemodynamic variables measured in the ED predict patients who at high
risk of death, admission to ICU, and have shock?
- Does a refined LiPS definition better predict mortality and ICU admission?
- Do advanced haemodynamic predictors and/or refined LiPS predict better than experienced
physicians the presence and classification of patients with shock, mortality and ICU
admission?
This study will answer two main questions:
1. What is the probability that a patient has shock?
2. What type of shock does the patient have?
We propose:
1. To investigate whether advanced haemodynamic variables using USCOM predict 7-day
mortality and ICU admission.
2. To investigate whether advanced haemodynamic variables using USCOM improve the detection
and classification of shock.
3. To validate and refine Li's a priori Pragmatic Shock (LiPS) method for detecting and
classifying shock.
4. To evaluate clinical experience for shock.
5. To inform on the feasibility of future studies
After ethics and institutional approval is obtained from we will conduct a prospective,
single-centre, cohort study on 354 adult patients with possible shock associated with an
acute illness or injury who present to the Emergency Department of the University Hospital of
Wales, and follow them up for 7 days. 354 is a credible number to confirm that the strategy
works.
Written consent will be obtained either from the patient or a relative wherever possible but
a waiver of consent apply to patients who, because of confusion, unconsciousness or severe
disability, may be unable to give consent. In these cases, consent will first be sought from
a second doctor and/or nurse. Thereafter, consent will be obtained from the patient or a
relative as soon as practically possible.
The challenge is to discover a strategy that has a sensitivity >67% and specificity >72% for
determining in-hospital mortality in clinically deteriorating or potentially shocked
patients.